Zobrazeno 1 - 10
of 30
pro vyhledávání: '"X.V. Thomas"'
Autor:
Lieke Brouwer, Kamija S. Phiri, Job C. J. Calis, Eveliina Karelehto, X.V. Thomas, Michael Boele van Hensbroek, Sylvie M. Koekkoek, Alvin X. Han, Brenda M. Westerhuis, Darsha Amarthalingam, Sjoerd Rebers, Katja C. Wolthers, Andrea H. L. Bruning, Dasja Pajkrt
Publikováno v:
Archives of virology, 164(3), 799-806. Springer Wien
Archives of Virology, 164(3), 799-806. Springer Vienna
Archives of virology, 164(3), 799-806. Springer-Verlag Wien
Archives of Virology
Archives of Virology, 164(3), 799-806. Springer Vienna
Archives of virology, 164(3), 799-806. Springer-Verlag Wien
Archives of Virology
Parechoviruses (PeVs) are highly prevalent viruses worldwide. Over the last decades, several studies have been published on PeV epidemiology in Europe, Asia and North America, while information on other continents is lacking. The aim of this study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce650816c678133b949d76385d57de7
https://pure.amc.nl/en/publications/high-frequency-and-diversity-of-parechovirus-a-in-a-cohort-of-malawian-children(6ed35bc8-2fe4-425b-89b7-bdb1a662df13).html
https://pure.amc.nl/en/publications/high-frequency-and-diversity-of-parechovirus-a-in-a-cohort-of-malawian-children(6ed35bc8-2fe4-425b-89b7-bdb1a662df13).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Menno D. de Jong, Janke Schinkel, Tara L. Kieffer, Cynthia K. Y. Ho, James C. Sullivan, Sjoerd Rebers, X.V. Thomas, Matthijs R.A. Welkers, Henk W. Reesink, Richard Molenkamp
Publikováno v:
Journal of virological methods, 219, 28-37. Elsevier
We compared 454 amplicon sequencing with clonal sequencing for the characterization of intra-host hepatitis C virus (HCV) NS3 variants. Clonal and 454 sequences were obtained from 12 patients enrolled in a clinical phase I study for telaprevir, an NS
Publikováno v:
Clinical infectious diseases, 57(Suppl. 2), S105-S110. Oxford University Press
Most new cases of hepatitis C virus (HCV) infections in the developed world are associated with injection drug use. However, treatment for people who inject drugs (PWID) is controversial, as successful treatment risks being followed by new infection.
Autor:
René Minnaar, Dasja Pajkrt, X.V. Thomas, Sjoerd Rebers, Katja C. Wolthers, Janke Schinkel, M.D. de Jong, L.M. van der Linden, Andrea H. L. Bruning
Publikováno v:
Clinical Microbiology and Infection
Clinical microbiology and infection, 22(12), 1002.e9-1002.e14. Elsevier Limited
Clinical microbiology and infection, 22(12), 1002.e9-1002.e14. Elsevier Limited
Rhinoviruses (RVs) are frequently detected respiratory viruses that cause mild common cold symptoms, but may also lead to more severe respiratory tract infections. The large number of RV types, classified into species A, B and C, hampers clear insigh
Autor:
Sjoerd Rebers, Janke Schinkel, Menno D. de Jong, Richard Molenkamp, Maria Prins, Bart P. X. Grady, Joost W. Vanhommerig, Cynthia K. Y. Ho, Marc van der Valk, Jan van der Meer, X.V. Thomas
Publikováno v:
AIDS (London, England), 29(17), 2287-2295. Lippincott Williams and Wilkins
OBJECTIVE High rates of hepatitis C virus (HCV) reinfections among HIV-infected men who have sex with men (MSM) following clearance of a primary infection suggest absence of protective immunity. Here, we investigated the incidence of HCV super and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::853ea12893345635020cedbcbb508519
https://pure.amc.nl/en/publications/genetic-characterization-of-multiple-hepatitis-c-virus-infections-following-acute-infection-in-hivinfected-men-who-have-sex-with-men(0f0360b8-be5f-47e5-b9a6-2e0d20fa208f).html
https://pure.amc.nl/en/publications/genetic-characterization-of-multiple-hepatitis-c-virus-infections-following-acute-infection-in-hivinfected-men-who-have-sex-with-men(0f0360b8-be5f-47e5-b9a6-2e0d20fa208f).html
Autor:
Peter J. Sterk, Joanne G. Wildenbeest, Rogier R. Jansen, Dasja Pajkrt, X.V. Thomas, Marc P. van der Schee, Lonneke van der Linden, Katja C. Wolthers, René Minnaar, Menno D. de Jong, Andrea H. L. Bruning
Publikováno v:
Journal of clinical virology, 73, 120-126. Elsevier
Journal of Clinical Virology
Journal of Clinical Virology
Highlights • Rhinoviruses (RV) frequently cause respiratory tract infections in young children. • We evaluated characteristics of RV infections in relation to clinical outcome. • In young children clinical outcome was not related to RV species
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088fbeef464515f75a5219fa2c46f707
https://pure.amc.nl/en/publications/clinical-virological-and-epidemiological-characteristics-of-rhinovirus-infections-in-early-childhood-a-comparison-between-nonhospitalised-and-hospitalised-children(18007dfb-e5ca-4f26-b030-ac5846228c1b).html
https://pure.amc.nl/en/publications/clinical-virological-and-epidemiological-characteristics-of-rhinovirus-infections-in-early-childhood-a-comparison-between-nonhospitalised-and-hospitalised-children(18007dfb-e5ca-4f26-b030-ac5846228c1b).html
Autor:
X.V. Thomas, M. A. Treitel, R.J. de Knegt, Richard Molenkamp, Christine J. Weegink, Janke Schinkel, H. W. Reesink, J. de Bruijne, E. Hughes, J.F. Bergmann, H.L.A. Janssen, Sjoerd Rebers
Publikováno v:
Journal of viral hepatitis, 20(11), 779-789. Wiley-Blackwell
Journal of Viral Hepatitis, 20(11), 779-789. Wiley-Blackwell Publishing Ltd
Journal of Viral Hepatitis, 20(11), 779-789. Wiley-Blackwell Publishing Ltd
Narlaprevir, a hepatitis C virus (HCV) NS3/4A serine protease inhibitor, has demonstrated robust antiviral activity in a placebo-controlled phase 1 study. To study evolutionary dynamics of resistant variants, the NS3 protease sequence was clonally an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3cfa41a51fc55f74b257a692b52180b
https://pure.amc.nl/en/publications/evolutionary-dynamics-of-hepatitis-c-virus-ns3-protease-domain-during-and-following-treatment-with-narlaprevir-a-potent-ns3-protease-inhibitor(4896dcbd-c176-44f6-ad52-db1230549611).html
https://pure.amc.nl/en/publications/evolutionary-dynamics-of-hepatitis-c-virus-ns3-protease-domain-during-and-following-treatment-with-narlaprevir-a-potent-ns3-protease-inhibitor(4896dcbd-c176-44f6-ad52-db1230549611).html
Autor:
G.E.L. van den Berk, Janke Schinkel, MH Prins, X.V. Thomas, T. van Laar, Christine J. Weegink, Peter V. Markov, Oliver G. Pybus, Sem J. Aronson
Publikováno v:
Markov, P V, van de Laar, T J W, Thomas, X V, Aronson, S J, Weegink, C J, van den Berk, G E, Prins, M, Pybus, O G & Schinkel, J 2012, ' Colonial History and Contemporary Transmission Shape the Genetic Diversity of Hepatitis C Virus Genotype 2 in Amsterdam ', Journal of Virology, vol. 86, no. 14, pp. 7677-7687 . https://doi.org/10.1128/JVI.06910-11
Journal of Virology, 86(14), 7677-7687. American Society for Microbiology
Journal of virology, 86(14), 7677-7687. American Society for Microbiology
Journal of Virology, 86(14), 7677-7687. American Society for Microbiology
Journal of virology, 86(14), 7677-7687. American Society for Microbiology
Evolutionary analysis of hepatitis C virus (HCV) genome sequences has provided insights into the epidemic history and transmission of this widespread human pathogen. Here we report an exceptionally diverse set of 178 HCV genotype 2 (HCV-2) isolates f
Autor:
Tara L. Kieffer, Hendrik W. Reesink, Christine J. Weegink, Cynthia K. Y. Ho, Janke Schinkel, Sjoerd Rebers, Michel de Vries, Richard Molenkamp, Joep de Bruijne, James C. Sullivan, X.V. Thomas
Publikováno v:
PLoS ONE, 7(7). Public Library of Science
PLoS ONE, Vol 7, Iss 7, p e41191 (2012)
PLoS ONE
PLoS ONE, Vol 7, Iss 7, p e41191 (2012)
PLoS ONE
Background & Aims Telaprevir, a hepatitis C virus NS3/4A protease inhibitor has significantly improved sustained viral response rates when given in combination with pegylated interferon alfa-2a and ribavirin, compared with current standard of care in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::056e485fcbd76fbef03d989f7fce40ef
https://pure.amc.nl/en/publications/evaluation-of-persistence-of-resistant-variants-with-ultradeep-pyrosequencing-in-chronic-hepatitis-c-patients-treated-with-telaprevir(6e285787-3885-4927-9533-e370e11d5646).html
https://pure.amc.nl/en/publications/evaluation-of-persistence-of-resistant-variants-with-ultradeep-pyrosequencing-in-chronic-hepatitis-c-patients-treated-with-telaprevir(6e285787-3885-4927-9533-e370e11d5646).html